IDiyas

For the Inventor, By the Inventor

Monsey, NY, United States of America

Ving J Lee

USPTO Granted Patents = 40

Average Co-Inventor Count = 2.8

ph-index = 24

Forward Citations = 1,208(Granted Patents)


Location History:

  • Airmont, NY (US) (1980)
  • Monsey, NY (US) (1986 - 1999)

Company Filing History:

goldMedal39 out of 3,580 
 
American Cyanamid Company
 patents
silverMedal1 out of 832,680 
Other
 patents

Years Active: 1980-1999

Loading Chart...
40 patents (USPTO):Explore Patents
1. 5886175 - 7-(substituted)-8-(substituted)-9-(substitued (1999-03-23),
2. 5639742 - 9-[(substituted (1997-06-17),
3. 5567692 - 9-[(substituted glycyl) amido)]-6-demethyl-6-deoxytetracyclines (1996-10-22),
4. 5530117 - 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines (1996-06-25),
5. 5529990 - Method for treating bacterial infection with novel (1996-06-25),
6. 5512553 - 7-(substituted)-8-(substituted)-9-(substituted (1996-04-30),
7. 5495032 - Process for producing 7-(substituted)-8-(substituted-9-[(substituted (1996-02-27),
8. 5495031 - Process for the production of 7-(substituted)-9-[(substituted (1996-02-27),
9. 5495030 - 9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines (1996-02-27),
10. 5495018 - 7-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines (1996-02-27),
11. 5494903 - 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines (1996-02-27),
12. 5466684 - 7-(substituted)-9-[(substituted (1995-11-14),
13. 5457096 - 7-(substituted)-8-(substituted)-9-[(substituted (1995-10-10),
14. 5442059 - 9-[(substituted glycyl)amido)]-6-demethyl-6-deoxytetracyclines (1995-08-15),
15. 5430162 - 7-(substituted)-8-(substituted)-9-substituted (1995-07-04),

Title: Ving J Lee: Innovator in Antibiotic Research

Introduction

Ving J Lee, a prolific inventor based in Monsey, NY, has made significant contributions to the field of antibiotic research through his innovative compounds. With a remarkable portfolio of 40 patents, Lee has established himself as a leading figure in the development of new antibiotic agents.

Latest Patents

Among his latest patents are two noteworthy inventions. The first, titled "7-(substituted)-8-(substituted)-9-(substituted)," describes compounds that serve as intermediates for the preparation of 6-demethyl-6-deotetracycline antibiotic agents. The second, referred to as "9-[(substituted)," details compounds with specific formulas that play a crucial role as antibiotic agents. These inventions highlight Lee's ongoing commitment to combating bacterial infections through innovative chemical solutions.

Career Highlights

Ving J Lee's impressive career includes tenure at American Cyanamid Company, where he honed his skills in pharmaceutical research and development. His dedication to advancing antibiotic therapies has had a lasting impact on the medical community, particularly in the fight against resistant bacteria.

Collaborations

During his career, Lee has collaborated with notable professionals such as Phaik-Eng Sum and Raymond T Testa. These partnerships have not only enriched his research but have also fostered a collaborative spirit in the pursuit of innovative solutions in antibiotic development.

Conclusion

In summary, Ving J Lee's extensive patent portfolio and dedication to antibiotic research affirm his status as a key innovator in the pharmaceutical landscape. His groundbreaking inventions continue to pave the way for new therapeutic approaches and demonstrate the vital role of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…